Robert A. Anders

Rosai-Dorfman disease presenting in the gastrointestinal tract.

cDNA microarray analysis of macroregenerative and dysplastic nodules in end-stage hepatitis C virus-induced cirrhosis.

Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection.

Dysregulated LIGHT expression on T cells mediates intestinal inflammation and contributes to IgA nephropathy.

Caveolin and thrombospondin expression during hepatocellular carcinogenesis.

The role of herpesvirus entry mediator as a negative regulator of T cell-mediated responses.

The critical role of LIGHT in promoting intestinal inflammation and Crohn's disease.

Contribution of the lymphotoxin beta receptor to liver regeneration.

Fas-positive T cells regulate the resolution of airway inflammation in a murine model of asthma.

Glycogen pseudoground glass change in hepatocytes.

Selective targeting of the LIGHT-HVEM costimulatory system for the treatment of graft-versus-host disease.

Preoperative assessment of hepatocellular carcinoma tumor grade using needle biopsy: implications for transplant eligibility.

Biopsy considerations in the diagnosis of hepatic masses.

Hepatotoxicity associated with dietary supplements containing anabolic steroids.

Elucidation of a universal size-control mechanism in Drosophila and mammals.

The hippo pathway in human upper gastrointestinal dysplasia and carcinoma: a novel oncogenic pathway.

Opposing regulation of T cell function by Egr-1/NAB2 and Egr-2/Egr-3.

Gadd45beta promotes hepatocyte survival during liver regeneration in mice by modulating JNK signaling.

Expression of Yes-associated protein in common solid tumors.

T cell-derived lymphotoxin regulates liver regeneration.

Metastatic renal cell carcinoma within a hepatic focal nodular hyperplasia: a case report and review of the literature.

Hepatitis in common variable immunodeficiency.

The Ape-1/Ref-1 redox antagonist E3330 inhibits the growth of tumor endothelium and endothelial progenitor cells: therapeutic implications in tumor angiogenesis.

Immunostaining of plasma cells in primary biliary cirrhosis.

KRAS2 mutations in human pancreatic acinar-ductal metaplastic lesions are limited to those with PanIN: implications for the human pancreatic cancer cell of origin.

Johns Hopkins course: 8th annual Current Topics in Gastrointestinal and Liver Pathology.

Successful liver transplantation for Budd-Chiari syndrome in a patient with paroxysmal nocturnal hemoglobinuria treated with the anti-complement antibody eculizumab.

Depth of tumor invasion better predicts prognosis than the current American Joint Committee on Cancer T classification for distal bile duct carcinoma.

Tc17 CD8 T cells: functional plasticity and subset diversity.

Genomic and immunophenotypical differences between hepatocellular carcinoma with and without cirrhosis.

The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals.

Arginase-1: a new immunohistochemical marker of hepatocytes and hepatocellular neoplasms.

Autoimmune hepatitis in patients with primary Sjögren's syndrome: a series of two-hundred and two patients.

Hepatocellular carcinoma in a teenager with perinatally acquired HIV Infection without hepatitis B or C coinfection: a case report.

Variation in lymph node assessment after colon cancer resection: patient, surgeon, pathologist, or hospital?

The role of liver-directed surgery in patients with hepatic metastasis from a gynecologic primary carcinoma.

Hedgehog activity, epithelial-mesenchymal transitions, and biliary dysmorphogenesis in biliary atresia.

Hyperplastic Luschka ducts: a mimic of adenocarcinoma in the gallbladder fossa.

Tyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancer.

Yes-associated protein 1 is widely expressed in human brain tumors and promotes glioblastoma growth.

Refining the definition of perioperative mortality following hepatectomy using death within 90 days as the standard criterion.

Hilar cholangiocarcinoma: tumor depth as a predictor of outcome.

A polymeric nanoparticle formulation of curcumin (NanoCurcâ„¢) ameliorates CCl4-induced hepatic injury and fibrosis through reduction of pro-inflammatory cytokines and stellate cell activation.

Shifting trends in liver-directed management of patients with colorectal liver metastasis: a population-based analysis.

Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma.

A Polymeric Nanoparticle Encapsulated Hedgehog Pathway Inhibitor HPI-1 (NanoHHI) Inhibits Systemic Metastases in an Orthotopic Model of Human Hepatocellular Carcinoma.

Expression of glypican-3 in undifferentiated embryonal sarcoma and mesenchymal hamartoma of the liver.

Sarcina organisms in the gastrointestinal tract: a clinicopathologic and molecular study.

Expression of Yes-associated protein modulates Survivin expression in primary liver malignancies.

Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape.

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.

Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP.

Yes-associated protein regulates the hepatic response after bile duct ligation.

Durable Cancer Regression Off-treatment and Effective Re-induction Therapy with an Anti-PD-1 Antibody.

HIF-2α inhibits hepatocellular carcinoma growth through the TFDP3/E2F1-dependent apoptotic pathway.